74 related articles for article (PubMed ID: 8571182)
21. Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease.
Gustavsson A; Eskilsson J; Landberg T; Svahn-Tapper G; White T; Wollmer P; Akerman M
Ann Oncol; 1990 Sep; 1(5):355-63. PubMed ID: 2261376
[TBL] [Abstract][Full Text] [Related]
22. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo AD; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G
Cancer J Sci Am; 1999; 5(5):275-82. PubMed ID: 10526668
[TBL] [Abstract][Full Text] [Related]
23. Radiotherapy considerations in patients with Hodgkin's disease who receive mediastinal radiotherapy and anthracycline-containing chemotherapy.
Plowman PN
Clin Oncol (R Coll Radiol); 1998; 10(6):384-91. PubMed ID: 9890541
[TBL] [Abstract][Full Text] [Related]
24. Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
Josting A; Nogová L; Franklin J; Glossmann JP; Eich HT; Sieber M; Schober T; Boettcher HD; Schulz U; Müller RP; Diehl V; Engert A
J Clin Oncol; 2005 Mar; 23(7):1522-9. PubMed ID: 15632410
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
Wang WH; Li YX; Song YW; Jin J; Liu YP; Wang SL; Zhou LQ; Liu XF; Yu ZH; Han JZ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):218-21. PubMed ID: 16875611
[TBL] [Abstract][Full Text] [Related]
26. Thallium-201 scintigraphy is not predictive of late cardiac complications in patients with Hodgkin's disease treated with mediastinal radiation.
Girinsky T; Cordova A; Rey A; Cosset JM; Tertian G; Pierga JY
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1503-6. PubMed ID: 11121655
[TBL] [Abstract][Full Text] [Related]
27. [Radiotherapy in adults with localized supradiaphragmatic stages CS I/II of Hodgkin's disease. 2. The special aspects of radiotherapy: dosage, fractionation, focal volumes, risks, conclusions].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Oct; 169(10):570-83. PubMed ID: 8235981
[TBL] [Abstract][Full Text] [Related]
28. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
[TBL] [Abstract][Full Text] [Related]
29. [Stage I and II Hodgkin's disease with enlarged mediastinum in adults. Apropos of 24 cases].
Touboul E; Beral HM; Grigoraki V; Raphael M; Taelman P; Chantelard JV; Gabarre J; Bro S; Guerin RA
Rev Mal Respir; 1988; 5(6):619-27. PubMed ID: 3146115
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
[TBL] [Abstract][Full Text] [Related]
31. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
32. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML
J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107
[TBL] [Abstract][Full Text] [Related]
33. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
34. Alternating chemotherapy and radiation therapy in the treatment of advanced Hodgkin's disease.
Grigoraki V; Merle-Beral H; Touboul E; Gabarre J; Lesty C; Binet JL
Nouv Rev Fr Hematol (1978); 1988; 30(4):219-24. PubMed ID: 3194187
[TBL] [Abstract][Full Text] [Related]
35. Stage I Hodgkin disease: radiation therapy and chemotherapy at the University of Texas M. D. Anderson Cancer Center, 1996-1997.
Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Hess MA; Tucker SL; Cabanillas F; Cox JD
Radiology; 1998 Sep; 208(3):739-47. PubMed ID: 9722855
[TBL] [Abstract][Full Text] [Related]
36. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies.
Schellong G; Riepenhausen M; Bruch C; Kotthoff S; Vogt J; Bölling T; Dieckmann K; Pötter R; Heinecke A; Brämswig J; Dörffel W
Pediatr Blood Cancer; 2010 Dec; 55(6):1145-52. PubMed ID: 20734400
[TBL] [Abstract][Full Text] [Related]
37. Cardiopulmonary sequelae after treatment for Hodgkin's disease: increased risk in females?
Lund MB; Kongerud J; Boe J; Nome O; Abrahamsen AF; Ihlen H; Forfang K
Ann Oncol; 1996 Mar; 7(3):257-64. PubMed ID: 8740789
[TBL] [Abstract][Full Text] [Related]
38. Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation.
Dubray B; Henry-Amar M; Meerwaldt JH; Noordijk EM; Dixon DO; Cosset JM; Thames HD
Radiother Oncol; 1995 Sep; 36(3):211-7. PubMed ID: 8532908
[TBL] [Abstract][Full Text] [Related]
39. Follow-up thallium-201 scintigraphy after mantle field radiotherapy for Hodgkin's disease.
Pierga JY; Maunoury C; Valette H; Socie G; Girinski T; Tchernia G; Henry-Amar M; Desgrez A; Cosset JM
Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):871-6. PubMed ID: 8478238
[TBL] [Abstract][Full Text] [Related]
40. Cardiac lesions after mediastinal irradiation for Hodgkin's disease.
Glanzmann C; Huguenin P; Lütolf UM; Maire R; Jenni R; Gumppenberg V
Radiother Oncol; 1994 Jan; 30(1):43-54. PubMed ID: 8153379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
